Journals / BEYOGLU EYE JOURNAL / 2021 / Cilt: 6 - Sayı: 1

Voriconazole Treatment for Fungal Chorioretinitis After Obesity Surgery

Pages
74–78
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Many clinical tests may have negative results but a careful fundoscopic examination can determine signs of fungemia-related chorioretinitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Presently described is a case of fungal septicemia diagnosed based on a fundus examination and successfully treated with voriconazole.
📊
Key Findings & Data:A 48-year-old woman who had undergone sleeve gastrectomy 20 days prior due to obesity was referredto the ophthalmology clinic for blurred vision in the right eye.
💡
Conclusion & Impact:Many clinical tests may have negative results but a careful fundoscopic examination can determine signs of fungemia-related chorioretinitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Presently described is a case of fungal septicemia diagnosed based on a fundus examination and successfully treated with voriconazole. A 48-year-old woman who had undergone sleeve gastrectomy 20 days prior due to obesity was referredto the ophthalmology clinic for blurred vision in the right eye. The initial examination indicated visual acuity of only light perception in the right eye and 0.00 logMAR in the left eye. Anterior segment examination and light reaction results were normal in both eyes. The vitreous was clear. A central, hemorrhagic, hypopigmented lesion 1/3 optic disc diameter in size, was located in the right fovea, bulging from the retina. There were 3 or 4 small hypopigmented lesions in both peripheral retinas. The examination findings and patient history suggested fungal chorioretinitis. The patient was treated with intravenous voriconazole at a maintenance dose of 200 mg 2 times a day following a loading dose of 6 mg/kg 2 times a day for 48 hours according to the recommendation of the infectious diseases clinic. Multimodal imaging using fundus photography, fluorescein angiography, and spectral domain optical coherence tomography was performed throughout treatment. The patient's daily follow-up revealed no deterioration and improvement was seen on the third day. Endogenous fungal chorioretinitis is a rare infection, but it remains important in ophthalmology due to the high potential to cause severe visual loss and the limited diagnosis and treatment options. Patients who are susceptible to fungemia and have a recurrent fever may be referred to an ophthalmologist. Many clinical tests may have negative results but a careful fundoscopic examination can determine signs of fungemia-related chorioretinitis.

🔖

Cite This Article

SAVUR, F., KALDIRIM, H., ATALAY, K. (2021). Voriconazole Treatment for Fungal Chorioretinitis After Obesity Surgery. BEYOGLU EYE JOURNAL, Cilt: 6 - Sayı: 1, 74–78. https://ajindex.com/articles/353065

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Darin R. Goldman. Candida chorioretinitis. Atlas of retinal OCT: Optical coherence tomography. USA: Elsevier; 2018. p. 129–31
  2. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414–21
  3. Aguilar GL, Blumenkrantz MS, Egbert PR, McCulley JP. Candida endophthalmitis after intravenous drug abuse. Arch Ophthalmol 1979;97:96–100
  4. Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 2012;153:162–6.e1
  5. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995;20:1531–4
  6. Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, et al. Ocular manifestations of candidemia. Clin Infect Dis 2011;53:262–8
  7. Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE Jr, et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 1994;101:1302–9
  8. Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore) 2003;82:97–105
  9. Ness T, Pelz K, Hansen LL. Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmologica Scandinavica 2007;85:852–6
  10. Brod RD, Flynn HW Jr, Clarkson JG, Pflugfelder SC, Culbertson WW, Miller D. Endogenous Candida endophthalmitis. Management without intravenous amphotericin B. Ophthalmology 1990;97:666–72; disc: 672–4
  11. Dellon AL, Stark WJ, Chetien PB. Spontaneous resolution of endogenous Candida endophthalmitis complicating intravenous hyperalimentation. Am J Ophthalmol 1975;79:648–54
  12. Osthoff M, Hilge R, Schulze-Döbold C, Bogner JR. Endogenous endophthalmitis with azole-resistant Candida albicans-Case report and review of the literature. Infection 2006;34:285–8
  13. Riddell J, Comer GM, Kauffman CA. Treatment of endo- genous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis 2011;52:648–53
  14. Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant fungal endophthalmitis:case series. Retina 2006;26:935–9
  15. Biju R, Sushil D, Georgy NK. Successful management of presumed Candida endogenous endophthalmitis with oral voriconazole. Indian